Search

Pharming Group NV

Atvērts

1.13 3.96

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

1.087

Max

1.148

Galvenie mērījumi

By Trading Economics

Ienākumi

6.7M

1.6M

Pārdošana

19M

90M

P/E

Sektora vidējais

105.4

50.373

EPS

0.002

Peļņas marža

1.744

Darbinieki

407

EBITDA

7.1M

5M

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-52M

746M

Iepriekšējā atvēršanas cena

-2.83

Iepriekšējā slēgšanas cena

1.13

Pharming Group NV Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 1. nov. 23:51 UTC

South Korea's October Manufacturing PMI Release on November 2 Expected to Reflect Mixed Sentiment Amid Global Economic Pressures.

2026. g. 1. nov. 23:51 UTC

Australia's Building Permits MoM data for September 2026 expected to rise by 2.1% amid cautious market sentiment and ongoing economic pressures.

2026. g. 1. nov. 23:51 UTC

Upcoming ISM Manufacturing Employment Report on November 2, 2026, Expected to Reflect Cautious Sentiment Amid Global Economic Uncertainties.

2026. g. 1. nov. 23:11 UTC

Macro News
Correlated Moves

Gold prices are advancing, supported by rising crude oil prices and increased investor interest in safe-haven assets amid geopolitical tensions in the Middle East.

2026. g. 1. nov. 23:11 UTC

Macro News
Correlated Moves

Silver prices are advancing amid rising crude oil prices and geopolitical tensions, as investors seek safe-haven assets in response to global equity market declines.

2026. g. 1. nov. 23:11 UTC

Brazil's Industrial Production Expected to Decline by 0.2% in September Amid Economic Concerns

2026. g. 1. nov. 23:11 UTC

Australia's Balance of Trade Expected to Show AUD 1.2 Billion Surplus for September Amid Global Economic Uncertainties

2026. g. 1. nov. 23:11 UTC

Macro News

The Dow Jones Industrial Average is advancing today, recovering from Friday's selloff amid geopolitical tensions and rising oil prices, despite earlier session pullbacks.

2026. g. 1. nov. 23:11 UTC

Macro News

The S&P 500 Index is modestly higher despite significant declines in global equity markets and rising oil prices amid geopolitical tensions in the Middle East.

2026. g. 1. nov. 23:11 UTC

Macro News

Natural gas prices are advancing sharply amid rising crude oil prices and fears of supply disruptions linked to ongoing conflicts involving Iran.

2026. g. 1. nov. 23:11 UTC

The EUR/JPY is trading higher at the start of the new week, despite broader market apprehension following a significant U.S. stock selloff on Friday.

2026. g. 1. nov. 23:11 UTC

Macro News
Correlated Moves

Platinum is trading modestly higher as crude oil prices surge amid supply disruption fears linked to ongoing conflicts in the Middle East.

2026. g. 1. nov. 23:11 UTC

Macro News

The Nasdaq 100 Index is advancing, showing a modest increase despite significant declines in global equity markets amid rising oil prices and geopolitical tensions.

2026. g. 1. nov. 23:11 UTC

Macro News

The Russell 2000 Index is modestly higher, gaining ground despite significant declines in major U.S. indices amid rising oil prices and geopolitical tensions.

2026. g. 1. nov. 23:01 UTC

Macro News

The Australian dollar is under pressure amid rising fuel prices and potential $700 million losses at Alaska Air, showing weakness in early trading.

2026. g. 1. nov. 23:01 UTC

The GBP/AUD is advancing as the new trading week begins, showing resilience amid recent volatility in U.S. equity markets.

2026. g. 1. nov. 23:01 UTC

The EUR/AUD is advancing in early trading as the new week begins, following a flat performance since Friday's close.

2026. g. 1. nov. 23:01 UTC

The EUR/CZK is advancing in early trading, showing a slight uptick since Friday's close amid a cautious investor outlook following U.S. market volatility.

2026. g. 1. nov. 23:01 UTC

The EUR/PLN is advancing in early trading this week, positioned near the upper end of its one-month range amid broader market volatility.

2026. g. 1. nov. 22:51 UTC

UK MPC Meeting Minutes on November 5, 2026: Investors Brace for Insights on Interest Rate Changes Amid Rising Inflation and Geopolitical Tensions.

2026. g. 1. nov. 22:31 UTC

Mexican Consumer Confidence Index Set for November 4 Release Amid Ongoing Economic Concerns and Weak Sentiment.

2026. g. 1. nov. 22:11 UTC

Mexico's Business Confidence Data Release on November 3, 2026 Expected to Show Continued Pessimism Amidst Stagnant Manufacturing Trends.

2026. g. 1. nov. 22:11 UTC

Brazil's Central Bank to announce interest rate decisions on November 3, 2026, amid cautious economic sentiment and inflation concerns.

2026. g. 1. nov. 22:01 UTC

Mortgage Rates Decline to 7.37%, Offering Hope for Homebuyers Amid High Prices and Cautious Market Sentiment Ahead of November Data Release

2026. g. 1. nov. 21:41 UTC

Turkey's Balance of Trade Data Release on November 4 Expected to Highlight Ongoing Trade Deficit Amid Economic Optimism and Geopolitical Tensions.

2026. g. 1. nov. 21:41 UTC

Australia's Ai Group Industry Index set for release on November 3 amid cautious market expectations following a significant decline and ongoing investor concerns in the tech sector.

2026. g. 1. nov. 21:31 UTC

Euro Area Retail Sales Expected to Decline by 0.1% Amid Economic Uncertainty and Rising Inflation, with Implications for GDP Growth and Monetary Policy

2026. g. 1. nov. 21:31 UTC

France's Industrial Production MoM data for September 2026 set to release on November 5, with a cautious market anticipating only a modest increase of 0.5% amid rising borrowing costs and negative fiscal outlook.

2026. g. 1. nov. 21:31 UTC

France's Trade Deficit Expected at €5.8 Billion Amid Negative Outlook and Economic Concerns Ahead of November 6 Report

2026. g. 1. nov. 21:31 UTC

Italy's Retail Sales MoM report on November 5 forecasts a modest 0.2% increase amid fluctuating consumer spending trends and inflationary pressures.

Salīdzinājums

Cenas izmaiņa

Pharming Group NV Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

0

Pirkt

0

Turēt

0

Pārdot

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Pharming Group NV

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
help-icon Live chat